Grant Avenue Capital, a lower middle market healthcare-focused private equity firm, completed the investment in CREO, a provider of strategy, M&A, digital transformation, cybersecurity, IT quality and regulatory compliance consulting services to life sciences and healthcare organizations. Financial terms were not disclosed. “We are very excited to embark on the next phase of our Company’s journey with the support of Grant Avenue. CREO and Grant Avenue share a vision of making good companies better so that they can create a better, healthier world. Grant Avenue’s significant healthcare investment experience, deep industry network, and flexible capital approaches make the firm an ideal partner for us as we continue to build on our successful growth,” Susan Acker-Walsh, CREO CEO.